The relevant Disclosure is attached.
Awaiting price reaction for this filing.
Fortis Healthcare has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, confirming adherence to SEBI regulations, secretarial standards, and listing requirements. The Practicing Company Secretary found no new non-compliances during the review period across areas like insider trading, related party transactions, subsidiary disclosures, and website disclosures. The report references two pending legacy SEBI matters from 2022 — penalties of Rs. 1 crore on Fortis Healthcare, Rs. 50 lakh on Fortis Hospitals, and Rs. 1 crore on Escorts Heart Institute — relating to alleged fund diversion by erstwhile promoters. Both orders have been appealed before SAT, which has stayed them subject to deposit of 50% of the penalty amount. The matters remain pending adjudication.
This is a routine annual compliance filing with no new adverse findings against the company, signaling clean regulatory standing for FY25. Investors should note that legacy SEBI cases from the previous promoter era are still unresolved but currently stayed, posing limited near-term risk.